Targeted therapies in the treatment of non small cell lung cancer: reality and hopes

Curr Opin Oncol. 2004 Mar;16(2):126-9. doi: 10.1097/00001622-200403000-00007.
No abstract available

Publication types

  • Editorial
  • Review

MeSH terms

  • Angiogenesis Inhibitors / therapeutic use
  • Antineoplastic Agents / pharmacology
  • Antineoplastic Agents / therapeutic use*
  • Apoptosis / drug effects
  • Carcinoma, Non-Small-Cell Lung / drug therapy*
  • Disease-Free Survival
  • Eicosanoids / antagonists & inhibitors
  • Eicosanoids / metabolism
  • ErbB Receptors / antagonists & inhibitors
  • ErbB Receptors / metabolism
  • Humans
  • Lung Neoplasms / drug therapy*
  • Quality of Life
  • Signal Transduction / drug effects
  • Treatment Outcome
  • Vascular Endothelial Growth Factor A / antagonists & inhibitors
  • Vascular Endothelial Growth Factor A / metabolism

Substances

  • Angiogenesis Inhibitors
  • Antineoplastic Agents
  • Eicosanoids
  • Vascular Endothelial Growth Factor A
  • ErbB Receptors